BioLife Solutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24	33.04	91.54	27.9	19.44	69.86
Short-Term Investments	58.42	55.89	9.2	16.29	43.26	-
Cash & Short-Term Investments	82.42	88.93	100.74	44.18	62.7	69.86
Cash Growth	0.80%	-11.72%	127.99%	-29.53%	-10.25%	-22.72%
Accounts Receivable	-	-	-	7.9	33.94	23.22
Inventory	35.59	30.16	29.01	27.16	34.9	28.35
Other Current Assets	6.54	9.53	10.54	41.36	6.91	4.67
Total Current Assets	135.2	136.56	148.76	120.6	138.45	126.09
Net Property, Plant & Equipment	23.88	22.18	16.53	19.48	48.27	46.61
Other Intangible Assets	3.65	4.26	5.57	12	32.09	152.15
Goodwill	208.59	208.59	208.59	212.3	224.74	224.74
Long-Term Investments	30.65	31.25	5.62	5.62	6.4	4.37
Other Long-Term Assets	45.52	3.05	14.42	42.71	0.28	0.33
Total Assets	447.49	405.88	399.49	412.71	450.23	554.29
Accounts Payable	2.48	1.49	3.36	2.27	15.37	14.95
Accrued Expenses	6.8	11.97	12.12	9.12	9.78	6.87
Current Portion of Long-Term Debt	-	5	10.94	6.29	1.81	0.86
Current Portion of Leases	2.59	2.24	1.46	1.29	3.02	2.91
Other Current Liabilities	2.07	2.28	4.85	23.22	14.6	17.12
Total Current Liabilities	13.95	22.98	32.73	42.18	44.58	42.7
Long-Term Debt	-	-	5	17.56	23.79	6.35
Long-Term Leases	13.15	10.66	12.65	8.7	15.09	16.76
Other Long-Term Liabilities	0.4	0.36	0.2	6.62	2.58	10.43
Total Long-Term Liabilities	13.54	11.02	17.84	32.87	41.46	33.54
Total Liabilities	27.49	34	50.58	75.05	86.04	76.24
Common Stock	-	-	-	0.05	0.04	0.04
Additional Paid-in Capital	713.57	711.4	683.94	652.88	611.74	585.4
Accumulated Other Comprehensive Income	-0.21	0.13	0.02	-0.35	-0.68	-0.28
Retained Earnings	-293.41	-339.7	-335.1	-314.92	-246.92	-107.11
Total Common Shareholders' Equity	419.95	371.84	348.86	337.66	364.19	478.05
Shareholders' Equity	420	371.89	348.91	337.66	364.19	478.05
Total Liabilities & Equity	447.49	405.88	399.49	412.71	450.23	554.29
Total Debt	15.74	17.9	30.04	33.83	43.71	26.88
Net Cash (Debt)	66.68	71.03	70.69	10.36	18.99	42.98
Net Cash Growth	15.06%	0.48%	582.55%	-45.46%	-55.82%	-45.77%
Net Cash Per Share	1.36	1.46	1.53	0.24	0.44	1.12
Book Value	419.95	371.84	348.86	337.66	364.19	478.05
Book Value Per Share	8.56	7.64	7.57	7.72	8.46	12.42
Tangible Book Value	207.71	159	134.71	113.36	107.36	101.16
Tangible Book Value Per Share	4.23	3.27	2.92	2.59	2.49	2.63

SEC Filings: 10-K · 10-Q